9-11) Given the rise in the number of articles published in Iran, (12,13) we aimed to evaluate the extent of adherence to the CONSORT Statement
in pharmacological RCTs published in Iranian medical journals from September 2012 to September 2013.
sup] compared the quality score for reports of RCTs published in 1994 (pre-CONSORT) and in 1998 (post-CONSORT), which showed that the use of the CONSORT statement
is associated with improvements in the quality of reports of RCTs.
The first CONSORT statement
was developed in 1996 as empirical evidence implied that authors reported trials badly due to the possible association with bias .
We had come across the mentioned problem with this particular aspect of the CONSORT statement
while we were surveying how well the published randomized controlled trials, the majority of which were, as usual, multicenter, followed suit with the CONSORT.
His topic was adhering to CONSORT statement
in reporting RCTs.
Improving the reporting of pragmatic trials: an extension of the CONSORT statement
Many journals he said has adopted this Consort statement
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement
1 Recent reviews assessing quality of reporting of RCTs have suggested that although CONSORT statement
has improved reporting consistency not all published papers adhere to reporting standards and completeness of reporting is suboptimal.
The CONSORT statement
is a robust, evidence-based checklist for reporting RCTs.
Evaluating single-incision slings in female stress urinary incontinence: the usefulness of the CONSORT statement